[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349525-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349525-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","selenof-functions-as-a-tumor-suppressor-in-skin-cancer-short-communication","SELENOF functions as a tumor suppressor in skin cancer - Short Communication","","Selenoprotein F (SELENOF) is a selenium-sensitive selenoprotein whose role in cancer remains unclear. Using Selenof knockout (KO) mice exposed to DMBA and a Western high-fat, high-calorie diet, all KO mice developed tumors faster than wild-type, with increased cutaneous squamous cell carcinomas and papillomas. Tumor-driver effects intensified with the Western diet. In human skin cancer microarrays, SELENOF expression was markedly reduced, and transcriptomics showed disrupted epidermal development and keratinocyte differentiation alongside increased oxidative phosphorylation and mitochondrial metabolic programs, supporting SELENOF loss as a causal tumor-suppressive switch.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/selenof-functions-as-a-tumor-suppressor-in-skin-cancer-short-communication/349525/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/selenof-functions-as-a-tumor-suppressor-in-skin-cancer-short-communication/349525.png","ImageObject",300,407,{"name":42,"@type":43},"PakDamar76","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What experimental model was used to test SELENOF’s role in skin cancer development?","Question",{"text":63,"@type":64},"Selenof knockout (KO) mice were exposed to the carcinogen DMBA and fed a high-fat, high-calorie Western diet.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did SELENOF loss affect tumor outcomes after DMBA treatment?",{"text":68,"@type":64},"All Selenof KO mice developed tumors more rapidly than wild-type mice, with a higher frequency of DMBA-induced skin lesions including cutaneous squamous cell carcinomas and benign papillomas.",{"name":70,"@type":61,"acceptedAnswer":71},"What human data supported the relevance of the mouse findings?",{"text":72,"@type":64},"Analysis of a skin cancer microarray showed dramatic reduction of SELENOF expression across SCC, basal cell carcinoma, melanomas, and matched adjacent normal tissue, with pathway changes consistent with impaired epidermal development and altered mitochondrial metabolism.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349525,1790145535,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Redox Biology 96 (2026) 104335  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| Short Communication\u003Cbr>SELENOF functions as a tumor suppressor in skin cancer\u003Cbr>Brenna Flowers a , An Zhang a, Weiwei Mab, Alexandra Zigrossia, Madeline Warrick a, Jacob K. Phillips a, Mitchell F. Denninga , Maarten C. Bosland c,d, Li Liub, Alan M. Diamond c, Irida Kastrati a,* \u003Cbr>a Department of Cancer Biology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, 60153, USA b Department of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL, 60612, USAc Department of Pathology, College of Medicine, University of Illinois Chicago, Chicago, IL, 60612, USA\u003Cbr>d Center for Global Health, College of Medicine, University of Illinois Chicago, Chicago, IL, 60612, USA |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>SELENOF\u003Cbr>Skin carcinogenesis\u003Cbr>Squamous Cell Carcinoma (SCC) Oxidative phosphorylation Keratinocyte differentiation Western diet |  | Selenoprotein F (SELENOF) is one of the 25 human selenoproteins that is highly sensitive to fluctuations in bioavailable selenium, an essential micronutrient. Although SELENOF has been implicated in cancer etiology, its precise role remains unclear. To define its contribution to carcinogenesis, Selenof knockout (KO) mice were exposed to the potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and fed a high-fat, high-calorie Western diet. All Selenof KO mice developed tumors and did so more rapidly, whereas only 30% of wild-type mice developed tumors. This effect was further exacerbated by the Western diet regardless of Selenof status. Notably, the majority of DMBA-induced tumors in KO mice were skin lesions, predominantly cutaneous squamous cell carcinomas (SCCs) and benign papillomas. These tumors occurred at a four-fold higher frequency in KO mice than in wild-type controls, establishing SELENOF as a key tumor suppressor in the skin.\u003Cbr>To assess the relevance of these findings to human disease, we analyzed a skin cancer microarray containing patient samples of SCC, basal cell carcinoma, melanomas, and matched adjacent normal tissue. SELENOF expression was dramatically reduced across all tumor types relative to normal skin. Although the skin of Selenof KO mice appears histologically normal, transcriptomic profiling followed by enrichment analysis revealed significant downregulation of pathways related to epidermal development and keratinocyte differentiation as well as the upregulation of oxidative phosphorylation and mitochondrial metabolic pathways. Collectively, these findings support a causal link between SELENOF loss and skin cancer development and highlight a previously unrecognized role for SELENOF in safeguarding against skin carcinogenesis. Significance: Skin cancers are the most common human malignancies. SELENOF levels are significantly reduced in skin cancers, and experimental evidence establishes a critical tumor-suppressive role for SELENOF in the skin. |\n\n1. Introduction  \nSelenoprotein F (SELENOF; formerly SEP15) is one of the 25 humanselenoproteins that incorporate selenium as selenocysteine through arecoding of an in-frame UGA codon [1,2]. This specialized translational mechanism confers enhanced redox capacity; however, while several selenoproteins function as antioxidant enzymes, not all share this role [3]. Unlike some selenoproteins whose expression remains stable across a range of selenium intake, SELENOF expression is highly sensitive to dietary selenium availability [4]. Selenium status strongly correlates with survival among breast cancer patients [5], suggesting that SELENOF may contribute to selenium's anti-cancer effects. Experimental  \nstudies demonstrate that restoring SELENOF levels suppresses breast cancer cell growth ","cbCaieIgRNjp7REp","https://ap.wps.com/l/cbCaieIgRNjp7REp","pdf",5994224,12,"English","# Introduction\n## SELENOF biology and selenium sensitivity\n## Rationale and objective of the study","[{\"question\":\"What experimental model was used to test SELENOF’s role in skin cancer development?\",\"answer\":\"Selenof knockout (KO) mice were exposed to the carcinogen DMBA and fed a high-fat, high-calorie Western diet.\"},{\"question\":\"How did SELENOF loss affect tumor outcomes after DMBA treatment?\",\"answer\":\"All Selenof KO mice developed tumors more rapidly than wild-type mice, with a higher frequency of DMBA-induced skin lesions including cutaneous squamous cell carcinomas and benign papillomas.\"},{\"question\":\"What human data supported the relevance of the mouse findings?\",\"answer\":\"Analysis of a skin cancer microarray showed dramatic reduction of SELENOF expression across SCC, basal cell carcinoma, melanomas, and matched adjacent normal tissue, with pathway changes consistent with impaired epidermal development and altered mitochondrial metabolism.\"}]","SELENOF functions as a tumor suppressor in skin cancer - Short Communication | PDF",1790084171,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e71e0c2f425ffeb8e69d1d956b020c7f.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f9557d931e2141770212972540a1938.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c268dd157aa83f43e246b7311c91bd9.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b8cee39f3d6c06f9b15db471cec5a55.webp",980,1306]